Genius Sports Limited (GENI) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$6.46 +1.73% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot)

Genius Sports Limited (GENI) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D β€’ SELL / AVOID Cap $1.73B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERSELL / AVOID β€’ D
025507510048
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D Β· Rk D
Cash (9)Whales (13)SEC (5)Macro (13)CEO (8)
Each axis scored 0–20
12M PRICE TARGET CONE-4.5% Base Target
$12 Bull$6 Base$5 Bear
πŸ“¬ FREE GENI RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for GENI)Realized 20D OHLCV Swing Band: Β±12.5%
SEC FORM 4 Γ— 13F HEDGE FUNDS Γ— CONGRESSIONAL STOCK ACT

GENI Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales β†’
β–² Disclosed Buys: 0 ($0)β–Ό Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (GENI)

No recent open-market Form 4 cluster sales or emergency dumps flagged on GENI. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring GENI)

  • βœ“Walkthrough of GENI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
GENI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +48.17%⚑ TESTING RESISTANCE
2026-10-30O $6.42H $6.50L $6.22C $6.46VOL 7.43M
RES: $6.70SUP: $5.18SMA50: $6.67SMA200: $6.24
$9.82$8.25$6.67$5.10$3.52RES $6.70SUP $5.18$6.462026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

GENI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +31.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on GENI today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for GENI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for GENI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (GENI)

Consumer Discretionary Rank #677 of 1011 βš”οΈ BRSL vs GENI Full Matrix β†’

1. Head-to-Head Consumer Discretionary Peer Comparison (GENI vs. BRSL, PRSU, PRKS, STUB)

Industry: Services-Misc. Amusement & Recreation (51 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Genius Sports Limited (GENI) ranks #677 by composite RQD confidence (48/100, grade D) and #436 by equity capitalization ($1.73B). Within this direct 5-issuer industry benchmark cohort, PRKS leads on earnings valuation at 8.5x trailing P/E, while PRKS leads on capital efficiency and profitability with 17.2% ROIC and β€” gross margin. PRKS currently holds the highest overall quantitative score in the immediate peer group at 63/100 (C) compared with GENI at 48/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
GENI ACTIVE
Genius Sports Limited
D 48/100 β€” 23.0% -26.9% +1.73% $1.73B Benchmark Subject
BRSL
Brightstar Lottery PLC Trading under the Legal Name to begin at the market open on July 21 2025.
D 49/100 12.0x β€” 16.8% +3.34% $1.77B /brsl-vs-geni β†’
PRSU
Pursuit Attractions and Hospitality Inc.
D 46/100 66.4x 92.3% 3.9% +3.04% $1.51B /prsu-vs-geni β†’
PRKS
United Parks & Resorts Inc.
C 63/100 8.5x β€” 17.2% +1.97% $1.43B /prks-vs-geni β†’
STUB
StubHub Holdings Inc. (Class A)
D+ 53/100 β€” β€” -35.0% +3.93% $2.22B /stub-vs-geni β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001834489

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Genius Sports Limited (GENI) reported GAAP revenue of $669.5M (+31.0% vs. FY2024 revenue of $510.9M , and +62.1% cumulative change since FY2023) , GAAP net income of -$111.6M, operating cash flow of $86.4M, and free cash flow of $64.5M (-7.2% YoY). On the balance sheet, GENI closed FY2025 with $1.13B in total assets against $0 in total debt (Altman Z-Score: 1.43, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $669.5M -$111.6M $86.4M $64.5M $1.13B β€”
FY2024 (FY) 2024-12-31 $510.9M -$63.0M $81.9M $69.6M $792.3M β€”
FY2023 (FY) 2023-12-31 $413.0M -$85.5M $14.9M $14.9M β€” β€”

3. GENI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is GENI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Genius Sports Limited (NYSE: GENI) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $6.46 (+1.73% 1D, market cap $1.73B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 8/20. Across 1011 tracked Consumer Discretionary issuers, GENI ranks #677 in composite RQD confidence.

How does GENI compare to BRSL and PRSU in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Services-Misc. Amusement & Recreation), GENI carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 23.0%, and ROIC of -26.9%. By comparison, BRSL (Brightstar Lottery PLC Trading under the Legal Name to begin at the market open on July 21 2025.) holds a D grade (49/100 RQD, P/E 12.0x, ROIC 16.8%, cap $1.77B) and PRSU (Pursuit Attractions and Hospitality Inc.) posts a D grade (46/100 RQD, P/E 66.4x, ROIC 3.9%, cap $1.51B). Among the 5-stock peer group, PRKS leads on earnings multiple (8.5x) while PRKS leads on capital efficiency (17.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for GENI?

Per GENI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001834489), Genius Sports Limited generated $669.5M in revenue (+31.0% YoY), -$111.6M in net income, and $64.5M in free cash flow against $1.13B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is GENI trading relative to its 50-day, 200-day, and 52-week technical levels?

GENI last traded at $6.46 (+1.73% on volume of 5,216,306 shares), positioning the stock -3.15% below its 50-day simple moving average ($6.67) and +3.53% above its 200-day simple moving average ($6.24). Across its 52-week range of $3.83 to $11.58, GENI sits at the 33.9% percentile with a 14-day RSI of 48.2 (NEUTRAL RANGE) and an implied next-earnings move of Β±12.5% ($5.65 to $7.27).

GENI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Are GENI insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies GENI leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%